16-16-dimethylprostaglandin-f2alpha and Uremia

16-16-dimethylprostaglandin-f2alpha has been researched along with Uremia* in 1 studies

Other Studies

1 other study(ies) available for 16-16-dimethylprostaglandin-f2alpha and Uremia

ArticleYear
Comparative effects of indomethacin on hepatic enzymes and histology and on serum indices of liver and kidney function in the rat.
    British journal of experimental pathology, 1985, Volume: 66, Issue:5

    The effects of high-dose indomethacin (three daily dose, 8.5 mg/kg ip) on pathology and histology, on serum and urine biochemistry, and on various hepatic enzyme activities were studied in rats. Hepatic cytochrome P-450 and aminopyrine N-demethylase were decreased by 52-62%, but glucuronyl transferase fell by only 22%. Hepatic glucose-6-phosphatase, aryl esterase, 6-phosphogluconate dehydrogenase and sulphotransferase remained unchanged, while glucose-6-phosphate dehydrogenase increased by 29%. There were no widespread changes in hepatic and renal pathology or histology, but noteworthy was a mild, focal, centrilobular hepatic response. By contrast, there were severe intestinal lesions: the effects on hepatic enzymes might have been partly a consequence of the intestinal damage. There was a reversible uraemia and significant decreases (20-40% below normal) in both serum albumin and protein, while serum levels of creatinine and aspartate-amino-transferase activity remained constant. A reversible N-acetyl-beta-D-glucoseaminidase (NAG) enzymuria occurred (300% above normal), but no significant proteinuria (less than 300 mg/l). Administration of 16, 16-dimethylprostaglandin F2 alpha(0.5 mg/kg iv) concomitantly with the indomethacin greatly ameliorated the intestinal lesions and prevented the decreases in hepatic drug-metabolizing enzymes. Concomitant 16,16-dimethylprostaglandin F2 alpha did not, however, influence the indomethacin-induced decreases in serum protein, albumin or NAG-enzymuria. It was concluded that indomethacin had a highly selective effect causing a decrease in hepatic cytochrome P-450, which was not accompanied by severe damage to hepatocyte structure.

    Topics: Acetylglucosaminidase; Aminopyrine N-Demethylase; Animals; Cytochrome P-450 Enzyme System; Dinoprost; Dose-Response Relationship, Drug; Glucosephosphate Dehydrogenase; Glucuronosyltransferase; Indomethacin; Intestines; Kidney; Kidney Function Tests; Liver; Liver Function Tests; Male; Prostaglandins F, Synthetic; Rats; Rats, Inbred Strains; Serum Albumin; Uremia

1985